Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A framework for health information governance: a scoping review.
Ghaffari Heshajin S, Sedghi S, Panahi S, Takian A. Ghaffari Heshajin S, et al. Among authors: sedghi s. Health Res Policy Syst. 2024 Aug 15;22(1):109. doi: 10.1186/s12961-024-01193-9. Health Res Policy Syst. 2024. PMID: 39148078 Free PMC article. Review.
Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials.
Louis E, Schreiber S, Panaccione R, Bossuyt P, Biedermann L, Colombel JF, Parkes G, Peyrin-Biroulet L, D'Haens G, Hisamatsu T, Siegmund B, Wu K, Boland BS, Melmed GY, Armuzzi A, Levine P, Kalabic J, Chen S, Cheng L, Shu L, Duan WR, Pivorunas V, Sanchez Gonzalez Y, D'Cunha R, Neimark E, Wallace K, Atreya R, Ferrante M, Loftus EV Jr; INSPIRE and COMMAND Study Group. Louis E, et al. JAMA. 2024 Sep 17;332(11):881-897. doi: 10.1001/jama.2024.12414. JAMA. 2024. PMID: 39037800 Clinical Trial.
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease.
Peyrin-Biroulet L, Chapman JC, Colombel JF, Caprioli F, D'Haens G, Ferrante M, Schreiber S, Atreya R, Danese S, Lindsay JO, Bossuyt P, Siegmund B, Irving PM, Panaccione R, Cao Q, Neimark E, Wallace K, Anschutz T, Kligys K, Duan WR, Pivorunas V, Huang X, Berg S, Shu L, Dubinsky M; SEQUENCE Study Group. Peyrin-Biroulet L, et al. N Engl J Med. 2024 Jul 18;391(3):213-223. doi: 10.1056/NEJMoa2314585. N Engl J Med. 2024. PMID: 39018531 Clinical Trial.
A methodological quality review of citations of randomized controlled trials of diabetes type2 in leading clinical practice guidelines and systematic reviews.
Aletaha A, Malekpour MR, Keshtkar AA, Baradaran HR, Sedghi S, Mansoori Y, Hajiani M, Delavari S, Habibi F, Razmgir M, Saeedi S, Soltani A, Nemati-Anaraki L. Aletaha A, et al. Among authors: sedghi s. J Diabetes Metab Disord. 2023 Oct 19;23(1):101-114. doi: 10.1007/s40200-023-01328-9. eCollection 2024 Jun. J Diabetes Metab Disord. 2023. PMID: 38932844 Free PMC article. Review.
Sevoflurane-mediated modulation of oxidative myocardial injury.
Sedghi S, Khadra WZ, Pourafkari L, Knight PR, Alderson FA, Nader ND. Sedghi S, et al. J Cardiovasc Thorac Res. 2023;15(3):138-144. doi: 10.34172/jcvtr.2023.31724. Epub 2023 Sep 23. J Cardiovasc Thorac Res. 2023. PMID: 38028722 Free PMC article.
A Scoping Review of Adopted Information Extraction Methods for RCTs.
Aletaha A, Nemati-Anaraki L, Keshtkar A, Sedghi S, Keramatfar A, Korolyova A. Aletaha A, et al. Among authors: sedghi s. Med J Islam Repub Iran. 2023 Sep 4;37:95. doi: 10.47176/mjiri.37.95. eCollection 2023. Med J Islam Repub Iran. 2023. PMID: 38021383 Free PMC article. Review.
80 results